Live Webinars

Dietary Supplement Regulation January 2021 Webinar Banner

Dietary Supplement Regulation: Recognizing Fact From Fiction

Wednesday, January 20 | 1-2 PM CST

Caution: This webinar may support healthy levels of skepticism.

While many in the dietary supplement industry comply fully with federal law, some bad actors sell products that are adulterated and/or misbranded in violation of the Federal Food, Drug, and Cosmetic Act. This webinar focuses on this subset of dietary supplements, particularly

  1. supplements tainted with undeclared active pharmaceutical ingredients;
  2. supplements that contain declared adulterants, such as amphetamine derivatives, steroids, or investigational new drugs; and
  3. supplements impermissibly marketed with claims to treat diseases.

Presenters will cover the regulatory framework governing these products; explain why these products continue to be readily available to patients; and provide pharmacists with the information they need to protect the public from harm.

Presenters

Headshot of January webinar presenter, Justin Macy

Justin Macy, PharmD, JD

Justin Macy leads NABP’s Digital Health team, which both verifies legitimate pharmacy community members and conducts research on illegal actors. Justin specializes in the intersection of law, technology, and health care with a focus on pharmacy practice and drug regulations. Prior to joining NABP, Justin was a specialist in Amazon’s Consumer Legal department and Associate Director of Innovation at LegitScript.

Headshot of January webinar presenter, Niamh Lewis

Niamh Lewis, JD

Niamh Lewis is a Regulatory Expert for NABP’s Digital Health team. She is an attorney who specializes in the online sale of medicines, dietary supplements, and CBD, as well as related FDA and international regulatory matters. Recently, Niamh co-authored the internet pharmacy law chapter for the American Bar Association’s treatise on e-Health.

CPE Credit

The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.


Pharmacists and Patient Safety ISMP Webinar

Pharmacists and Patient Safety:

ISMP Medication Error Reports and Self-Assessment Tools

Wednesday, November 18 | 1-2 PM CDT

As members of the health care team, pharmacists and pharmacy technicians play an important role in improving patient safety by reducing medication errors. The Institute for Safe Medication Practices (ISMP), a nonprofit patient safety organization, is devoted entirely to preventing medication errors and providing tools, resources, and educational programs for health care professionals and consumers to improve patient safety. During this webinar, ISMP experts will discuss how pharmacists can improve patient safety through proactive use of its self-assessment tools and medication error reports. ISMP will also share how outpatient and community pharmacies can proactively assess risk and reduce medication errors by implementing industry best practices in their workflow.

Presenters

Headshot of Presenter Michael Cohen

Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP

Michael Cohen is president and founder of the Institute for Safe Medication Practices (ISMP), a nonprofit health care organization that specializes in understanding the causes of medication errors, providing error-reduction strategies to the health care community, policy makers, and the public.

Cohen serves as co-editor of the ISMP Medication Safety Alert! publications and the ISMP consumer website, www.consumermedsafety.org. Cohen is also the chairperson of the International Medication Safety Network. He has served terms on the US FDA Drug Safety and Risk Management Advisory Committee and the Nonprescription Drugs Advisory Committee, and he is a current member of the USP Expert Committee on Labeling and Nomenclature as well as a consultant to FDA.

Headshot of Presenter Michael Gaunt

Michael Gaunt, PharmD

Michael Gaunt is a medication safety analyst and editor at the Institute for Safe Medication Practices (ISMP), which he joined in 2004. Gaunt co-coordinates the ISMP National Medication Errors Reporting Program and the ISMP National Vaccine Errors Reporting Program. He also serves as the editor of the monthly ISMP Medication Safety Alert! Community/Ambulatory Care newsletter. Gaunt represents ISMP at several organizations and partnerships, including the National Coordinating Council for Medication Error Reporting and Prevention, the Centers for Disease Control and Prevention PROTECT Initiative, and the Partnership for Health IT Patient Safety. Gaunt has published articles in the patient safety and pharmacy literature, including a monthly column in Pharmacy Times.

CPE Credit

The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.


Medication-Assisted Treatment: Overcoming Barriers to Improve Access for Patients

October 21, 2020 | 1-2 PM CDT

As regulators continue the fight against the opioid epidemic, the next step is ensuring medication-assisted treatment (MAT) is available for those patients suffering with opioid use disorder (OUD). Unfortunately, few OUD patients have access to MAT due to barriers such as limited access to treatment, the social stigma, cost, and lack of education. The federal government has prioritized expanding access to MAT as an important element in reducing OUDs and overdoses. Because pharmacists are among the most accessible and trusted health care providers, they are in a unique position to provide OUD patients with essential care through MAT.

This webinar will discuss the patient’s struggle with addiction and recovery, as well as steps states are taking to increase MAT access. NABP President Timothy Fensky will also provide an overview of his presidential initiative to increase access to pharmacist-provided MAT to those suffering from OUD.

Presenters

Headshot of MAT webinar presenter Timothy Fensky

Timothy Fensky, RPh, DPh, FACA, NABP President, Massachusetts Board of Pharmacy Member

Mr Fensky, a member of the Massachusetts Board of Registration in Pharmacy, is serving as NABP president. He has served one-year terms as president-elect and treasurer and a two-year term as an Executive Committee member. He currently represents NABP on the Pharmacy Compounding Advisory Committee to the United States Food and Drug Administration. He is the pharmacy administrator at Bournewood Health Systems and the chief pharmacy officer at Sullivan’s Health Care. He is recognized as a full fellow for the American College of Apothecaries and is an adjunct faculty member at both the Massachusetts College of Pharmacy and Health Sciences and Northeastern University, Bouvé College of Pharmacy and Health Sciences.

Headshot of MAT webinar presenter Erica Schlesinger

Erica Schlesinger, PharmD, Assistant Chief Pharmacist, Tennessee Department of Mental Health and Substance Abuse Services

Dr Erica Schlesinger is a West Tennessee native and graduate of the University of Tennessee Health Science Center College of Pharmacy (2017). She completed a PGY-1 managed care residency with the Tennessee Department of Mental Health and Substance Abuse Services and the University of Tennessee. Dr Schlesinger is currently the assistant chief pharmacist for the Tennessee Department of Mental Health and Substance Abuse Services. Her current interests and career goals are centered around health and mental health policy, mental health and addiction treatment and education, and health care informatics.

Headshot of MAT webinar presenter Jake Nichols

Jake Nichols, PharmD, MBA, Principal, Clinical Product Strategy at axialHealthcare, Specialist in Medications for Addiction Treatment

Jake Nichols is a pharmacist in long‐term recovery with extensive experience in community pharmacy, academia, primary care, managed care, and pharmaceutical industry. He specializes in the treatment of substances use disorders with a focus on medication for addiction treatment. Dr Nichols speaks regularly at conferences across the country, highlighting his experiences as a patient along with the importance and value of treatment. Through his 15‐year struggle with substance use, he found his calling in the field and has dedicated his career to helping patients and their families suffering from this debilitating chronic disease. By providing clinical support for clinicians treating patients with substance use disorder and serving as a vocal advocate for treatment, Dr Nichols has established himself as a key resource within the field. He has spoken at well over 200 pharmacy, nursing, and medical schools across the country, sharing his story with students and faculty. He also regularly facilitates patient and parent support groups. In 2017 he established his own education, clinical consulting, and treatment group called Professional Recovery Associates, of which he is President and CEO. Dr Nichols received his doctor of pharmacy degree from the Massachusetts College of Pharmacy in 2000 and his master’s degree in business administration from University of Massachusetts – Boston in 2007. Jake is currently employed as clinical lead for substance use disorder at Axial Healthcare in Nashville, TN.

CPE Credit

The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.